HIV Medicine

Papers
(The median citation count of HIV Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Issue Information94
84
Issue Information83
Late diagnosis of HIV infection in Warsaw: Estimating the scale of the problem and demographic trends75
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co‐administration51
48
45
The characteristics of men who have sex with men (MSM) using post‐exposure prophylaxis for sexual exposure (PEPSE) in the pre‐exposure prophylaxis (PrEP) era45
Effect of an opt‐out point‐of‐care HIV‐1 nucleic acid testing intervention to detect acute and prevalent HIV infection in symptomatic adult outpatients and reduce HIV transmission in Kenya: a randomiz40
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV38
Reflections on a specialist HIV menopause service37
Issue Information32
The data‐collection on adverse effects of anti‐HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV32
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)‐GeSIDA study conducted by the GeSIDA 12021 study group30
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV‐specific risk factors; the Archi‐Prevaleat project30
Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV‐related symptoms29
Areas with high HIV prevalence: A spatial analysis of nationwide claims data in Germany29
Telemedicine in HIV health care during the COVID‐19 pandemic: An implementation research study in Buenos Aires, Argentina27
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany26
Disparities in HIV continuum of care in the paediatric population: A real‐life study in Brazil25
IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study21
Aetiology of fever of unknown origin in people living with HIV: A systematic review and meta‐analysis19
No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people withHIV with profound immunosuppression19
19
Issue Information19
HIV cure: Are we going to make history?19
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium18
Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 111917
Efficacy of an electronic reminder for HIV screening in primary healthcare based on indicator conditions in Catalonia (Spain)16
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of non‐tuberculous mycobacteria 202416
Compassionate use of long‐acting cabotegravir plus rilpivirine for people living with HIV‐1 in need of parenteral antiretroviral therapy16
Are there additional adverse effects of testosterone use among men living with HIV?—Data from the PUSH! study15
Assessment of targeted intervention programme under the National AIDS Control Program among men who have sex with men in India15
Issue Information14
Associations between HIV infection and frailty status and its individual components: Are frailty components disproportionally affected?14
The value of herpes zoster prevention in people aging with HIV: A narrative review14
Using an automated decision support tool to improve HIV prescribing: A feasibility study14
The first AI‐based Chatbot to promote HIV self‐management: A mixed methods usability study14
Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process14
The effect of HIV and mpox co‐infection on clinical outcomes: Systematic review and meta‐analysis14
Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004–2020: A surveillance study14
Exploring implementation considerations forgeriatric‐HIVclinics: A secondary analysis from a scoping review onHIVmodels of geriatric care13
13
Microbial translocation is associated with advanced liver fibrosis among people with HIV13
Exploring the cascade of mental healthcare among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY study13
Special issue on Women and HIV to mark International Women’s Day13
13
Influence of physical activity on endothelial function in people living with HIV13
13
HIV‐associated thrombotic thrombocytopenic purpura (HIV‐TTP): A practical guide and review of the literature13
Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO412
Issue Information12
AI in medicine: No longer the future, but the present12
Access to care and impact on HIV treatment interruptions during the COVID‐19 pandemic among people living with HIV in British Columbia12
Issue Information12
“Editorial comment on: Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study”11
Increasing HIV early diagnosis by implementing an automated screening strategy in emergency departments11
11
Gender equality in leadership of HIV care cascade clinical trials: A methodological study11
Long‐acting injectable cabotegravir and rilpivirine in observational cohort studies: A systematic review on virological failure, resistance and re‐suppression outcomes in virally suppressed individual11
De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study10
10
An updated systematic review of HIV‐associated cryptococcal meningitis treatment strategies10
The role of HIV as a risk modifier for coronary endothelial function in young adults10
10
Knowledge and HIV‐related stigma among Portuguese healthcare professionals: A cross‐sectional analysis10
Predictors of poor health‐related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project10
Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors10
Oral Abstracts10
HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004–2023)10
Blood‐borne virus testing in emergency departments – a systematic review of seroprevalence, feasibility, acceptability and linkage to care9
Author Index9
Author Index9
Availability and stock‐outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda9
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy9
Late diagnosis of human immunodeficiency virus (HIV) and its associated factors in Asian countries: A systematic review9
Issue Information9
Virtual care pathways for people living with HIV: A mixed‐methods systematic review9
Point‐of‐care nucleic acid testing – a step forward in controlling the HIV epidemic: A review9
Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfection9
Blood pressure and metabolic outcomes after efavirenz‐ or dolutegravir‐based therapy started in acute HIV infection9
Issue Information9
Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV9
Cardiovascular risk knowledge stratified by predicted cardiovascular risk level among people living with HIV attending a tertiary HIV care centre in Gaborone, Botswana: A cross‐s8
“Real world” efficacy of bulevirtide in HBV/HDV‐related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spa8
Characterization of HIV‐1 drug resistance among patients with failure of second‐line combined antiretroviral therapy in central Ethiopia8
Frailty and frailty screening: A qualitative study to elicit perspectives of people living with HIV and their healthcare professionals8
Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study8
Themed Posters8
Biomarkers of inflammation and coagulation predict non‐AIDS‐defining events in a prospective cohort of virologically suppressed people living with HIV8
Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV‐1 vaccine formulations8
Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV8
Anticholinergic medications associated with falls and frailty in people with HIV8
Pneumocystis jirovecii pneumonia–Immune reconstitution inflammatory syndrome: A review of published cases8
Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment in people with human immunodeficiency virus‐1 (HIV‐1): A systematic literature rev8
Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study8
Immune response to ART initiation in advanced HIV infection7
Incidence and predictors of attrition from HIV treatment among adults living with HIV in high‐caseload facilities following implementation of universal test and treat strategy in7
Spatial and temporal trends in HIV/AIDS burden among South Asian countries from 1990 to 2021: A systematic examination of the Global Burden of Disease study 20217
Issue Information7
‘We want it all’:ARTpreferences assessed byDesirability ofOutcomeRanking7
Sleep deficiency among people living with human immunodeficiency virus: A growing challenge7
Short report: Characterizing HIV care among a clinical sample of transgender women living with HIV7
Managing cardiovascular risk in people living with HIV in Asia – where are we now?7
Late diagnosis of HIV: An updated consensus definition7
7
High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence7
Issue Information7
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS)7
Scars are frequently found as late sequelae in individuals affected by the 2022 mpox outbreak7
Study of natural product adverse events in adult HIV‐infected patients in Canada7
Issue Information7
Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross‐sectional analysis in Chongqing, China7
CROI 2024 BHIVA working group summary7
Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study6
Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)6
Implementation of frailty screening for older people living with HIV in Brighton, UK6
Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing6
Impact of HBV serological status on HIV virological efficacy of two‐drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with 6
Real‐world efficacy of bictegravir/emtricitabine/tenofovir alafenamide regimen in patients infected with HIV‐1 sub‐subtype A6 harbouring the L74I mutation6
One for all, all for one: neuro‐HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV6
Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study6
Frailty and sarcopenia among Turkish people aged 40 and above living with HIV6
British HIV Association guidelines for the management of HIV‐2 20216
Issue Information6
Weight changes, metabolic syndrome and all‐cause mortality among Asian adults living with HIV6
Lipid nanoparticles in antiretroviral therapy: A nanotechnology breakthrough for HIV/AIDS treatment6
SARS‐CoV‐2 vaccine immunogenicity for people living with HIV: A systematic review and meta‐analysis6
6
Anal cytological abnormalities and human papillomavirus infection in women living with HIV: A systematic review and meta‐analysis6
Impact of the COVID‐19 pandemic on the HIV care continuum and associated factors in middle‐income countries: A mixed‐methods systematic review6
6
Potential drug–drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey6
Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor use6
Intergenerational sex and early sexual debut are associated with HIV infection among transgender women in Paraguay6
Positive Outcomes: Validity, reliability and responsiveness of a novel person‐centred outcome measure for people with HIV6
Longitudinal analysis of new‐onset non‐AIDS‐defining diseases among people living with HIV: A real‐world observational study6
Issue Information6
Factors influencing the quality of life and social skills of children living with HIV: A case–control study6
Clinical outcomes of HIV–syphilis coinfection among patients with no neurological symptoms: a retrospective cohort study6
Optimizing statin prescriptions for people living with HIV: Evidence for improved communication and shared care between primary care and specialist HIV services6
5
No overall impact on rate of weight gain with integrase inhibitor‐containing regimens in antiretroviral‐naïve adults5
Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using a rifampicin‐based regimen: A retrospective observational case series5
Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV‐1 initiating first‐line therapy: 5‐year follow‐up from two phase III stud5
5
Issue Information5
Abstracts5
5
5
Issue Information5
Issue Information5
Direct, indirect and total effect of HIV coinfection on the risk of non‐liver‐related cancer in hepatitis C virus‐infected patients treated by direct‐acting antivirals: a mediation analysis5
Long‐term outcomes for children and adolescents with Kaposi sarcoma5
Issue Information5
Predictors of knowledge of and access to biomedical prevention among MSM and transgender men in Latin America: Results from the Latin American internet survey5
Low‐level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression5
Sexually transmitted and blood‐borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder: Findings from a Canadian pragmatic rand5
Erratum5
5
5
What are the predictors of change in multimorbidity among people with HIV? A longitudinal observational cohort study5
Cardiac adiposity as a modulator of cardiovascular disease in HIV5
Correction to ‘Abstracts of the 19th European AIDS Conference (#EACS2023), October 18–21, 2023, Warsaw, Poland’5
Cost of non‐communicable diseases in people living with HIV in the Central Denmark Region5
Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor‐ to dolutegravir‐based antiretroviral therapy: A prospective cohort study in Lesotho (DO‐REAL study)5
Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real‐world insights from BICSTaR cohorts5
5
4
Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial4
Collection of menopause data in studies of women living with HIV: A systematic literature review4
The spectrum of kidney biopsy findings in Chinese HIV‐infected patients4
Advanced HIV disease: A review of diagnostic and prophylactic strategies4
Potential drug–drug interactions in males living with HIV who use drugs to treat lower urinary tract symptoms4
BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia‐Pacific region4
Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies4
HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems4
Issue Information4
Cytomegalovirus infection among people living with HIV in Sweden: Case profiles, treatment strategies and patient outcomes at Karolinska University Hospital 2010–20204
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 20214
Severe ocular Mpox in person living with advanced HIV treated with extended course of tecovirimat4
People with HIV have a higher risk of COVID‐19 diagnosis but similar outcomes to the general population4
Use of antiretroviral therapy in pregnancy and association with birth outcome among women living with HIV in Denmark: A nationwide, population‐based cohort study4
Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (4
Late diagnosis of HIV in 2022: Why so little change?4
Antiretroviral drug switches to zidovudine‐based regimens and loss to follow‐up during the first COVID‐19 lockdown in Bali, Indonesia4
Switch to a raltegravir‐based antiretroviral regimen in people with HIV and non‐alcoholic fatty liver disease: A randomized controlled trial4
PrEP for women in Europe: a systematic literature review4
Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real‐life experience from a French cohort (2019–2023)4
4
Issue Information4
Issue Information4
Real‐world experience with weight gain among pregnant women living with HIV who are using integrase inhibitors4
No evidence of asymptomatic monkeypox infection in a highly sexually active MSM population in Austria4
Taxonomic and functional profile of the anorectal microbiota in HIV‐positive and HIV‐negative men who have sex with men, using a metagenomic approach4
Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV4
4
4
Failure to return pillbox is a predictor of being lost to follow‐up among people living with HIV on antiretroviral therapy in rural Tanzania4
Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 964
HIV and fracture: Risk, assessment and intervention4
4
Frailty in people 50 years or older living with HIV: A sex perspective4
Rapid HIV pre‐exposure prophylaxis (PrEP) initiation is safe and feasible: Experience from Wroclaw All Saints cohort in Poland 2017–20214
People diagnosed with HIV before continuing care in England are extremely unlikely to pass on HIV in England4
Strategies for strengthening same‐day ART initiation, tracing people living with HIV lost to follow‐up and viral load monitoring mechanisms in Ethiopia4
The incidence of and risk factors for hospitalized acute kidney injury among people living with HIV on antiretroviral treatment3
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of pulmonary opportunistic infections 20243
A new year, and big changes for HIV Medicine3
Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study3
3
Issue Information3
3
3
Metabolic syndrome and Pathobiological Determination of Atherosclerosis in Youth risk score in adolescents with and without perinatally acquired HIV in the Cape Town Adolescent and Antiretr3
Patients re‐engaging with HIV care in Guatemala: Prioritizing CD4 counting and screening for histoplasmosis and tuberculosis3
3
People with HIV and healthcare workers views on screening for cognitive impairment in people with HIV: A qualitative study3
Oral abstracts3
The recent natural history of human papillomavirus cervical infection in women living with HIV: A scoping review of meta‐analyses and systematic reviews and the construction of a hypothetic3
The use of non‐invasive imaging modalities for the assessment of skeletal muscle quantity and quality in people with HIV: A narrative review3
3
Poster Abstracts3
HIV pre‐exposure prophylaxis services, provision, and delivery in the European treatment network of HIV, hepatitis and global emerging infectious diseases (NEAT ID)3
Loss to follow‐up among human immunodeficiency virus‐positive postpartum women and its predictive factors: A retrospective study3
Outcomes of persistent low‐level viremia among HIV patients on antiretroviral therapy: A prospective cohort study3
3
Issue Information3
Issue Information3
Dolutegravir in real life: Self‐reported mental and physical health outcomes after transitioning from efavirenz‐ to dolutegravir‐based antiretroviral therapy in a prospective cohort study in Lesotho3
A call for health systems to monitor the health‐related quality of life of people living with HIV3
HIV disease hospitalizations and factors associated with in‐hospital mortality in Ecuador: A nationwide analysis from 2015 to 20233
Network analysis to prioritize issues for intervention to improve the health‐related quality of life of people with HIV in Spain3
Commentary on ‘Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)’3
Late diagnosis of HIV among Ukrainian refugees in the Czech Republic: A retrospective, observational study3
Issue Information3
Issue Information3
Comparing effectiveness of first‐line antiretroviral therapy between peri‐urban and rural clinics in KwaZulu‐Natal, South Africa3
3
Issue Information3
3
Breaking down global barriers: A multinational and multi‐community approach to combat stigma and enhance mental wellbeing in people with HIV3
Clinical staff attitudes towards opt‐out consent for blood‐borne virus screening in emergency departments in England3
Themed Poster Abstracts3
Transitions in treatment: A systematic review and meta‐aggregation of preferences and barriers in switching from oral to long‐acting injectable antiretroviral therapy among people living with HIV3
Correction to “Perception of medical care among women living with HIV aged 40 years or older—a European‐wide survey”3
Clinically recognized sleep disorders in people living with HIV3
Tobacco smoking and binge alcohol use are associated with incident venous thromboembolism in an HIV cohort3
High willingness to use injectable antiretroviral therapy among women who have been lost to follow‐up from HIV programmes: A nested cross‐sectional study3
A qualitative study of perspectives, experiences and priority outcomes for people living with HIV and frailty3
0.073970079421997